Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Surgery ; 166(3): 356-361, 2019 09.
Article in English | MEDLINE | ID: mdl-31104806

ABSTRACT

BACKGROUND: The suppressive effect of the increase in thyroid hormone in patients with toxic nodular goiter is thought to protect the extranodular thyroid tissue from thyroid malignancy. In this study, we aimed to evaluate the prevalence and features of thyroid cancer in patients with toxic nodular goiter who underwent thyroidectomy. METHODS: Medical data of patients who had solitary toxic or nontoxic nodules and underwent total thyroidectomy were reviewed retrospectively. We reviewed the clinical, laboratory, and histopathologic features of patients with toxic nodular goiter and nontoxic solitary nodules. RESULTS: There were 73 patients with toxic nodular goiter and 366 patients with nontoxic solitary nodules. Median age was greater in the toxic nodular goiter compared with nontoxic solitary nodules patients (50 years; range: 18-73 vs 42 years; range: 18-83, P < .001). Median nodule diameters were 40.9 mm (range: 11.0-98.0) and 23.3 mm (range: 4.9-99.0) in patients with toxic nodular goiter and nontoxic solitary nodules, respectively (P < .001). Histopathologic examination revealed thyroid cancer in 14 patients (19%) with toxic nodular goiter and 132 (36.1%) patients with nontoxic solitary nodules (P = .008). Median tumor diameters were 6 mm (range: 1-50) in toxic nodular goiter and 14 mm (range: 1-80) in nontoxic solitary nodules (P = .150). The malignant nodule was the hyperfunctioning nodule in 7 patients with toxic nodular goiter; 4 were follicular and 3 were papillary thyroid cancer. The other 7 malignant foci were located in the suppressed contralateral lobe, and all were papillary microcarcinomas. The incidence of thyroid cancer outside the main nodule was similar in 2 groups (P = .934). CONCLUSION: Thyroid cancer in patients operated for toxic nodular goiter was 19%, which is not as rare as previously thought. A careful histopathologic examination of both the hyperfunctioning nodule and the extranodular thyroid tissue might help to disclose an unexpected tumor foci when thyroidectomy is performed in patients with toxic nodular goiter.


Subject(s)
Goiter, Nodular/epidemiology , Thyroid Neoplasms/epidemiology , Adolescent , Adult , Aged , Female , Goiter, Nodular/complications , Goiter, Nodular/surgery , Humans , Hyperthyroidism , Male , Middle Aged , Prevalence , Thyroid Neoplasms/etiology , Thyroid Neoplasms/prevention & control , Thyroid Neoplasms/therapy , Thyroidectomy/adverse effects , Thyroidectomy/methods , Young Adult
2.
Case Reports Hepatol ; 2016: 6434507, 2016.
Article in English | MEDLINE | ID: mdl-26904324

ABSTRACT

The Mirizzi syndrome (MS) is an impacted stone in the cystic duct or Hartmann's pouch that mechanically obstructs the common bile duct (CBD). We would like to report laparoscopic subtotal cholecystectomy (SC) and resection of cholecystocolic fistula by the help of Tri-Staple™ in a case with type V MS and cholecystocolic fistula, for first time in the literature. A 24-year-old man was admitted to emergency department with the complaint of abdominal pain, intermittent fever, jaundice, and diarrhea. Two months ago with the same complaint, ERCP was performed. Laparoscopic resection of cholecystocolic fistula and subtotal cholecystectomy were performed by the help of Tri-Staple. At the eight-month follow-up, he was symptom-free with normal liver function tests. In a patient with type V MS and cholecystocolic fistula, laparoscopic resection of cholecystocolic fistula and SC can be performed by using Tri-Staple safely.

3.
Int J Surg Case Rep ; 16: 19-24, 2015.
Article in English | MEDLINE | ID: mdl-26408935

ABSTRACT

INTRODUCTION: We show the management of a delayed jejunal perforation, after irreducible femoral hernia operation with the help of negative pressure therapy (NPT) and delayed abdominal closure (DAC) with skin flap approximation in an elderly woman for the first time in the literature. PRESENTATION OF CASE: A 76 year-old woman was admitted to the emergency department with irreducible femoral hernia and ileus. After examining the femoral hernia sac and noting the presence of viable intestine within the hernia sac, a femoral hernia repair with mesh was performed. At postoperative day 1 she started to defecate and oral intake was started. The patient was discharged on postoperative day 3. On postoperative day 8, she was re-admitted to the emergency department with septic shock. The patient underwent reoperation. Septic abdomen and delayed perforation from strangulated part of the jejunum were seen. A jejunostomy was opened and patient was treated with open abdomen management and delayed abdominal closure with skin flap. The ostomy was closed 4 months later. DISCUSSION: The exact mechanism of delayed presentation of small bowel perforation remains controversial. Delayed intestinal perforation has rarely been reported after blunt abdominal trauma (BAT), conductive burn injuries of the bowel with cautery, or necrosis of strangulated bowel in a hernia sac. Open abdomen (OA) management is a life-saving and challenging strategy in severe generalized peritonitis. CONCLUSION: Delayed bowel perforation may develop after irreducible femoral hernia surgery. OA management with NPT and DAC with skin flap approximation are optimal treatment modalities for the hemodynamically instable patient.

4.
Turk J Gastroenterol ; 19(1): 40-4, 2008 Mar.
Article in English | MEDLINE | ID: mdl-18386239

ABSTRACT

BACKGROUND/AIMS: Retrorectal masses are rarely encountered in surgical practice, and they arise from congenital remnants, and from osteogenic, neurogenic, inflammatory, or metastatic processes. The majority of these masses are benign but many can be malignant, so they need to be treated with aggressive surgical management. METHODS: In this case series, eight patients with retrorectal masses of various etiologies are described, with particular emphasis on diagnosis and surgical treatment. RESULTS: In our series, we noted one duplication cyst, one tailgut cyst, one epidermoid cyst, one teratoma, one gastrointestinal stromal tumor, one epithelial malignant tumor, one inflammatory mass, and one retrorectal mass of as yet unknown origin. In three patients, complete excision via posterior sagittal approach was performed, one underwent abdominoperineal en-block proctectomy, two were only biopsied for neoadjuvant therapy, and two are waiting for operation. CONCLUSIONS: Surgery is the main treatment of choice, and the surgical strategy should be decided according to the localization and nature of the retrorectal mass.


Subject(s)
Rectal Neoplasms/diagnosis , Rectal Neoplasms/surgery , Adult , Cysts/diagnosis , Cysts/surgery , Female , Gastrointestinal Stromal Tumors/diagnosis , Gastrointestinal Stromal Tumors/surgery , Humans , Magnetic Resonance Imaging , Male , Middle Aged , Sacrococcygeal Region/pathology , Sacrococcygeal Region/surgery , Teratoma/diagnosis , Teratoma/surgery , Tomography, X-Ray Computed , Treatment Outcome
5.
Surg Laparosc Endosc Percutan Tech ; 17(5): 474-6, 2007 Oct.
Article in English | MEDLINE | ID: mdl-18049421

ABSTRACT

Mesh migration after laparoscopic inguinal hernia repair is an unusual and late complication. We report a 50-year-old man with persistent painless hematuria and urinary infection who underwent bilateral laparoscopic intraperitoneal onlay mesh 4 years ago. Polytetrafluoroethylene (PTFE) prosthesis was used and fixed with tackers. The patient underwent cystoscopy and laparotomy for excision of the migrated PTFE prosthesis into the bladder. This is the first case of PTFE prosthesis migration into the bladder after laparoscopic hernia repair. We also reviewed the literature involving migration of mesh after all inguinal hernial repairs.


Subject(s)
Fluorocarbon Polymers/adverse effects , Foreign-Body Migration/etiology , Hernia, Inguinal/surgery , Laparoscopy/adverse effects , Prosthesis Implantation/adverse effects , Surgical Mesh/adverse effects , Urinary Bladder , Cystoscopy , Diagnosis, Differential , Foreign-Body Migration/diagnosis , Foreign-Body Migration/surgery , Humans , Laparotomy/methods , Male , Middle Aged , Occlusive Dressings , Prosthesis Implantation/methods
6.
Saudi Med J ; 28(12): 1830-5, 2007 Dec.
Article in English | MEDLINE | ID: mdl-18060211

ABSTRACT

OBJECTIVE: To evaluate the effect of infliximab on adhesion formation and it's associated morbidity and complications. METHODS: This study was performed in the Faculty of Medicine, Gazi University, Turkey between July 2005 and October 2005. Thirty-five rats were randomly divided into 4 groups. Laparotomy was performed in the Sham group (n=5), whereas cecal abrasion was carried out in all other groups. After cecal abrasion 0.9% sodium chloride was administered in the saline group (n=10), infliximab was administered to the study group (n=10) and nothing was administered to the last group (n=10). Adhesion formation was evaluated with macroscopic and microscopic adhesion scoring systems. Peritoneal fluid samples and mesenteric lymph node biopsies were taken to rule out bacterial peritonitis. Blood and peritoneal irrigation fluid samples were taken to measure the Tumor necrosis factor-alpha (TNF-alpha) levels. RESULTS: Macroscopic adhesion scores showed fewer adhesions in the infliximab group. The infliximab group had significantly fewer adhesions than the abrasion control and saline groups. According to the histological findings, there were no statistically significant differences between the groups. CONCLUSION: Early blocking of the activity of TNF-alpha after cecal abrasion resulted in lower rates of adhesion formation, macroscopically. The TNF-alpha, a proinflammatory cytokine appears to be an important mediator for postoperative adhesion formation.


Subject(s)
Abdominal Wall/surgery , Anti-Inflammatory Agents/therapeutic use , Antibodies, Monoclonal/therapeutic use , Peritoneal Diseases/prevention & control , Postoperative Complications , Tumor Necrosis Factor-alpha/antagonists & inhibitors , Abdominal Wall/pathology , Animals , Infliximab , Male , Peritoneal Diseases/etiology , Rats , Rats, Wistar , Tissue Adhesions/etiology , Tissue Adhesions/prevention & control
SELECTION OF CITATIONS
SEARCH DETAIL
...